BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bejček J, Jurášek M, Spiwok V, Rimpelová S. Quo vadis Cardiac Glycoside Research? Toxins (Basel) 2021;13:344. [PMID: 34064873 DOI: 10.3390/toxins13050344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ren J, Gao X, Guo X, Wang N, Wang X. Research Progress in Pharmacological Activities and Applications of Cardiotonic Steroids. Front Pharmacol 2022;13:902459. [PMID: 35721110 DOI: 10.3389/fphar.2022.902459] [Reference Citation Analysis]
2 Hirasaki Y, Okabe A, Fukuyo M, Rahmutulla B, Mano Y, Seki M, Hoshii T, Namiki T, Kaneda A. Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genes. Chem Biol Interact 2022;360:109936. [PMID: 35447139 DOI: 10.1016/j.cbi.2022.109936] [Reference Citation Analysis]
3 Škubník J, Bejček J, Pavlíčková VS, Rimpelová S. Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses. Molecules 2021;26:5627. [PMID: 34577097 DOI: 10.3390/molecules26185627] [Reference Citation Analysis]
4 Barison A, Aimo A. Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine? Int J Cardiol 2021;339:106-7. [PMID: 34280422 DOI: 10.1016/j.ijcard.2021.07.026] [Reference Citation Analysis]